Supriya Lifescience Limited

Web: supriyalifescience.com NSE: SUPRIYA BSE: 543434 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

833 7(-1%)

Volume

6L as on 23, Jun

Open

715

High

720

Low

708

840

VWAP

955

52 Week High

1,085

52 Week Low

546

Viand Research Rating

Quality Score

73/100

Growth Score

67/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

6,707

No. of Shares

8.05

P/E

38.72

P/B

6.73

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

17.39

ROCE

Profit Growth

Listing Date

28-Dec-21

Promoter Holding

68.3%

FII Holding

5.16%

DII Holding

5.7%

Price Chart

Price Performance

1 Week1%

1 Month24%

3 Months74%

6 Months59%

1 Year59%

YTD59%

Moving Average

5 Day SMA933

10 Day SMA944

20 Day SMA932

30 Day SMA859

50 Day SMA784

61 Day SMA750

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	985	938	965	983
Resistance 2	965	935	950	964
Resistance 1	946	931	941	944
Pivot Point	926	928	926	925
Support 1	908	924	912	906
Support 2	888	920	903	887
Support 3	869	917	888	867

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.30%	(0.01) 68.28%	(0.01) 68.24%	(0.01) 68.24%	(0.01) 68.24%	(0.01) 68.24%	(0.01) 68.24%
FIIs	(0.01) 5.16%	(-0.31) 5.19%	(-1.31) 5.46%	(-0.41) 6.78%	(0.71) 7.19%	(0.51) 6.52%	(1.11) 6.03%	(-0.41) 4.95%	(0.81) 5.37%	(-0.81) 4.56%	(-0.41) 5.35%	(0.11) 5.73%	(-0.61) 5.66%	(-0.61) 6.24%	(0.81) 6.79%	(-1.11) 5.99%	(-3.21) 7.13%	(0.01) 10.30%
DIIs	(0.71) 5.70%	(-0.21) 5.00%	(0.41) 5.22%	(0.61) 4.86%	(-0.71) 4.26%	(-0.51) 4.93%	(0.01) 5.45%	(0.21) 5.48%	(-0.11) 5.30%	(-1.81) 5.39%	(-0.41) 7.17%	(-0.11) 7.54%	(-0.21) 7.65%	(-1.01) 7.89%	(-1.51) 8.88%	(2.61) 10.33%	(-0.21) 7.73%	(0.01) 7.90%
Public	20.83%	21.49%	21.02%	20.08%	20.25%	20.25%	20.22%	21.27%	21.04%	21.77%	19.19%	18.43%	18.43%	17.62%	16.09%	15.44%	16.90%	13.56%
No. of Shareholders	81,161	85,099	87,912	91,928	91,051	89,394	85,328	89,621	87,980	95,929	92,991	93,478	95,605	96,998	94,594	86,853	82,578	55,292

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	277	206	200	145	184	186	166	161	158	140	140	132	142	105	112	101	181	117	150
Sales Growth % (YoY)	50%	11%	20%	-10%	16%	33%	19%	22%	11%	33%	25%	30%	-22%	-10.1%	-25.3%	31.7%	37.2%	45%	-
Sales Growth % (QoQ)	34.5%	3%	37.9%	-21.2%	-1.1%	12%	3.1%	1.9%	12.9%	-	6.1%	-7%	35.2%	-6.2%	10.9%	-44.2%	54.7%	-22%	-
Expenses	179	134	127	93	117	120	101	98	103	99	108	88	87	91	84	70	106	79	70
Operating Profit	98	72	73	52	68	66	65	63	56	41	32	44	55	14	29	31	75	38	80
OPM %	35	35	36	36	37	36	39	39	35	30	23	34	39	13	25	31	42	33	53
Other Income	3	2	3	3	3	2	3	2	2	3	2	3	2	3	3	2	4	5	1
Interest	0	0	0	1	0	1	0	0	1	0	0	1	1	1	1	1	1	1	1
Depreciation	8	7	7	6	6	5	5	5	4	4	4	4	3	3	3	3	3	3	2
Profit before tax	92	67	68	47	64	63	62	60	53	40	30	43	53	13	27	30	75	40	78
Tax %	19	26	26	27	21	25	26	25	31	26	20	33	28	25	39	16	39	1	25
Net Profit	74	50	50	35	50	47	46	45	37	30	24	29	38	10	17	25	46	40	58
Net Profit Growth % (QoQ)	48%	-	42.9%	-30%	6.4%	2.2%	2.2%	21.6%	23.3%	25%	-17.2%	-23.7%	280%	-41.2%	-32%	-45.7%	15%	-31%	-
Net Profit Growth % (YoY)	48%	6.4%	8.7%	-22.2%	35.1%	56.7%	91.7%	55.2%	-2.6%	200%	41.2%	16%	-17.4%	-75%	-70.7%	-	-	-	-
TTM Net Profit	209	185	182	178	188	175	158	136	120	121	101	94	90	98	128	169	144	98	0
EPS in Rs	9.22	6.17	6.27	4.32	6.26	5.81	5.73	5.55	4.59	3.7	2.97	3.54	4.75	1.18	2.09	3.14	5.74	4.93	7.96

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Sales	828	696	570	461	530	391	312	278	213	184
Sales Growth %	18.9%	22.1%	23.7%	-13%	35.5%	25.5%	12.2%	30.5%	15.9%	-
Expenses	534	436	394	332	316	218	213	213	191	166
Operating Profit	294	261	176	129	214	173	98	65	22	17
OPM %	36	37	31	28	40	44	32	23	10	9
Other Income	11	10	11	9	8	5	11	8	9	7
Interest	2	2	5	3	4	4	7	10	11	12
Depreciation	28	20	16	12	10	7	6	5	5	5
Profit before tax	275	248	166	123	207	167	96	57	14	8
Tax %	24	24	28	27	27	26	24	31	40	30
Net Profit	209	188	119	90	152	124	73	39	9	6
Net Profit Growth %	11.2%	58%	32.2%	-40.8%	22.6%	69.9%	87.2%	333.3%	50%	-
EPS in Rs	25.98	23.35	14.8	11.17	18.86	16.89	50.11	26.93	5.96	3.87
Dividend Payout %	4	4	5	5	3	3	20	0	0	0

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash from Operating Activity	165	113	64	49	76	117	49	28	27
Cash from Investing Activity	-152	-174	-124	-60	-47	-25	5	-5	-27
Cash from Financing Activity	-8	-22	-10	150	-15	-29	-50	-20	-2
Net Cash Flow	4	-83	-70	139	15	62	4	3	-2

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Equity Capital	16	16	16	16	16	16	16	15	15	15	15	15
Reserves	1182	1066	981	890	799	683	600	254	134	79	40	31
Borrowings	5	5	5	6	5	22	27	72	82	90	130	140
Other Liabilities	154	116	110	101	101	98	92	105	105	69	60	55
Total Liabilities	1357	1203	1112	1012	921	820	735	445	336	253	245	241
Fixed Assets	689	458	453	308	310	262	190	100	99	85	91	89
CWIP	36	172	148	218	149	68	43	79	40	35	34	36
Investments	99	57	63	72	64	25	0	0	0	0	0	0
Other Assets	534	516	448	415	399	466	502	267	197	133	120	117
Total Assets	1357	1203	1112	1012	921	820	735	445	336	253	245	241

Delivery

#	Date	666 63% 1085	Value (Cr)	Q/T 33	Del 42	Del 57
1	22-Jul	840	17	17	47	8
2	21-Jul	864	21	13	41	9
3	20-Jul	837	9	14	49	4
4	17-Jul	829	22	19	43	9
5	16-Jul	851	11	16	35	4
6	15-Jul	852	10	18	45	5
7	14-Jul	871	30	21	35	10
8	13-Jul	845	19	18	51	10
9	10-Jul	855	21	18	47	10
10	9-Jul	875	30	21	37	11
11	8-Jul	862	58	28	31	18
12	7-Jul	842	85	27	42	36
13	6-Jul	865	215	31	31	66
14	3-Jul	979	19	17	45	9
15	2-Jul	995	34	17	35	12
16	1-Jul	1009	31	17	39	12
17	30-Jun	1018	112	24	34	39
18	29-Jun	971	36	20	45	16
19	25-Jun	928	28	26	48	13
20	24-Jun	953	23	16	35	8
21	23-Jun	961	54	25	38	20
22	22-Jun	928	19	16	38	7
23	19-Jun	932	12	21	46	6
24	18-Jun	932	17	26	38	7
25	17-Jun	914	28	23	49	14
26	16-Jun	947	23	22	45	10
27	15-Jun	955	49	22	32	16
28	12-Jun	977	70	27	32	22
29	11-Jun	937	34	16	39	13
30	10-Jun	952	69	21	27	19
31	9-Jun	963	32	21	38	12
32	8-Jun	919	25	18	35	9
33	5-Jun	948	59	25	24	14
34	4-Jun	952	84	26	25	21
35	3-Jun	901	90	24	24	21
36	2-Jun	917	214	29	21	45
37	1-Jun	1052	509	30	13	69
38	29-May	969	546	53	20	111
39	27-May	807	43	22	48	20
40	26-May	781	16	26	48	8
41	25-May	766	15	16	43	6
42	22-May	774	81	25	28	22
43	21-May	734	14	14	45	6
44	20-May	725	11	17	40	4
45	19-May	721	42	22	30	12
46	18-May	684	11	21	71	8
47	15-May	689	5	12	39	2
48	14-May	685	6	15	44	3

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	6,707c	62c	0.92
22-Jul	6,769c	192c	2.76
21-Jul	6,962c	302c	4.53
17-Jul	6,660c	173c	2.53
16-Jul	6,833c	53c	0.77
15-Jul	6,886c	43c	0.62
14-Jul	6,844c	35c	0.52
13-Jul	6,808c	189c	2.70
10-Jul	6,997c	57c	0.81
09-Jul	7,054c	101c	1.45
08-Jul	6,954c	125c	1.83
07-Jul	6,829c	156c	2.24
06-Jul	6,985c	1,368c	16.38
02-Jul	8,353c	153c	1.86
30-Jun	8,200c	648c	8.58
29-Jun	7,553c	5c	0.06
26-Jun	7,557c	138c	1.86
25-Jun	7,419c	253c	3.29
24-Jun	7,672c	70c	0.90
23-Jun	7,742c	305c	4.10
22-Jun	7,437c	64c	0.86
19-Jun	7,501c	128c	1.74
17-Jun	7,373c	209c	2.75
16-Jun	7,582c	121c	1.57
15-Jun	7,702c	137c	1.75
12-Jun	7,839c	13c	0.16
11-Jun	7,826c	0	0
10-Jun	7,826c	0	0

Stock Checklist

Price is above from 52 week high low average: 7%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 28 fund scheme(s) across 10 fund house(s) as of Jul26 · Total value ₹158 Cr · 12 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Abakkus Mutual Fund	2	0.94%	-	58.9
ITI Mutual Fund	6	1.73%	+0.26%	50
Quantum Mutual Fund	2	4.47%	+0.93%	21.7
WhiteOak Capital Mutual Fund	2	0.92%	+0.19%	12.3
Motilal Oswal Mutual Fund	4	0.12%	-	10.4
Samco Mutual Fund	2	1.43%	+1.43%	4.5
Groww Mutual Fund	2	0.01%	-	0.1
Bandhan Mutual Fund	4	0.07%	-	0
Angel One Mutual Fund	2	0.01%	-	0
Mirae Asset Mutual Fund	2	0.01%	-	0

Supriya Lifescience Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements